oral Toll-like receptor TLR7 agonist

3 mg Q2W, Ph. II for HIV/AIDS

from opt. of 8-oxopurine agonist

Science Translational Medicine

Gilead Sciences, Foster City, CA

8. The Gilead Toll-like receptor 7 (TLR7) agonist, vesatolimod (GS-9620), is a tolerated, low-dose oral TLR7 agonist. It is intended to induce immune cell activation to help eliminate reservoirs…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.